These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32467616)

  • 1. More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells.
    Rijkers G; Vervenne T; van der Pol P
    Cell Mol Immunol; 2020 Jul; 17(7):771-772. PubMed ID: 32467616
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin and resistance to SARS coronavirus 2.
    Cunningham L; Simmonds P; Kimber I; Basketter DA; McFadden JP
    J Allergy Clin Immunol; 2020 Jul; 146(1):52-53. PubMed ID: 32422144
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
    Bishop MR
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Loscocco GG
    Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired Cytotoxic CD8
    Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
    mBio; 2020 Sep; 11(5):. PubMed ID: 32948688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
    Sette A; Crotty S
    Nat Rev Immunol; 2020 Aug; 20(8):457-458. PubMed ID: 32636479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective humoral immunity in SARS-CoV-2 infected pediatric patients.
    Zhang Y; Xu J; Jia R; Yi C; Gu W; Liu P; Dong X; Zhou H; Shang B; Cheng S; Sun X; Ye J; Li X; Zhang J; Ling Z; Ma L; Wu B; Zeng M; Zhou W; Sun B
    Cell Mol Immunol; 2020 Jul; 17(7):768-770. PubMed ID: 32382126
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
    Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
    Hanley B; Roufosse CA; Osborn M; Naresh KN
    Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
    [No Abstract]   [Full Text] [Related]  

  • 14. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells found in coronavirus patients 'bode well' for long-term immunity.
    Leslie M
    Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2: a new aetiology for atypical lymphocytes.
    Gérard D; Henry S; Thomas B
    Br J Haematol; 2020 Jun; 189(5):845. PubMed ID: 32311762
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19 and Immunity in Aging Populations - A New Research Agenda.
    Koff WC; Williams MA
    N Engl J Med; 2020 Aug; 383(9):804-805. PubMed ID: 32302079
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19.
    Moratto D; Chiarini M; Giustini V; Serana F; Magro P; Roccaro AM; Imberti L; Castelli F; Notarangelo LD; Quiros-Roldan E
    J Clin Immunol; 2020 Oct; 40(7):970-973. PubMed ID: 32594342
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    Vignesh R; Shankar EM; Velu V; Thyagarajan SP
    Front Immunol; 2020; 11():586781. PubMed ID: 33101320
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 pneumonia: CD8
    Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
    Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.